Multiplex nucleic acid tests are making inroads in the clinical lab, and offer a great deal of promise in testing for a variety of infectious diseases. The first webinar in this series will explore how they are being used to detect a host of respiratory viruses, ranging from influenza to adenovirus.
The second webinar in the series is more about testing strategy than testing technology. During this program, Vanderbilt researchers will discuss their efforts to develop a multi-marker panel that can help detect sepsis in its earliest stage.
The final program in the series returns to molecular technologies, as a molecular biologist from The Johns Hopkins University provides an update on hepatitis C virus testing – exploring how its changing now that powerful antiviral therapies are available to treat the disease and virtually all babyboomers are being asked to undergo screening.
Multiplex Nucleic Acid Tests for Respiratory Viruses: Technology, Applications, and Clinical Relevance
Frederick S. Nolte, PhD, Professor, Director of Clinical Laboratories, and Director of Molecular Pathology, Department of Pathology & Laboratory Medicine, Medical University of South Carolina, Charleston, SC
Understanding the Role of Biomarkers in the Sepsis Diagnosis Algorithm
Alison Woodworth, PhD, Assistant Professor of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN
Jessica Colon-Franco, PhD, Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN
Diagnostic Testing for Hepatitis C Virus in the Era of Direct-Acting Antiviral Therapy
Alexandra Valsamakis, MD, PhD, Director, Clinical Virology and Molecular Microbiology, Department of Pathology, Division of Microbiology, The Johns Hopkins Hospital, Baltimore, MD